FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$13.58
-0.08 (-0.59%)
▼
5d:
-9.41%
30d:
+30.83%
90d:
+40.0%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FTRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FTRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.85
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.78
31.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $13.58, which is considered extended relative to its 30-day fair value range of $9.13 to $13.48. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.7) compared to its historical average (15.2). Remarkably, the market is currently pricing in an annual earnings decline of 5.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FTRE is in a strong uptrend. The price is currently testing key support at $13.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FTRE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.21 (+18.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FTRE is in a strong uptrend. The price is currently testing key support at $13.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FTRE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.21 (+18.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.13 -
$13.48
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($16.21)
- CAUTION: 5-day price weakness (-9.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$9.13 -
$13.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.51
Resistance Level
$16.20
Current Trend
Strong Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.70
Wall Street Target
$16.21
(+18.7%)
Revenue Growth (YoY)
-2.3%
Earnings Growth (YoY)
-57.4%
Profit Margin
-16.5%
Valuation Discount vs History
-5.8% cheaper
PE vs Historical
12.7 vs 15.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.8%
(market-implied from PE analysis)
1-Year Target
$12.87
(-6%)
2-Year Target
$12.12
(-11%)
3-Year Target
$11.42
(-16%)
3-Yr Target (if PE normalizes)
(PE: 13→15)
$13.67
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 33.5%)
$56.50
(+314%)
Base:
(SPY PE: 12.7, Growth: 33.5%)
$32.50
(+138%)
Bear:
(PE: 10.8, Growth: 33.5%)
$27.62
(+102%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.7 to 15.2
Stabilization Target:
$16.36
(+19.7%)
PE Expansion Potential:
+19.7%
Share & Embed Analysis
Last updated: May 18, 2026 1:09 PM ET
Data refreshes hourly during market hours. Next update: 2:09 PM
Data refreshes hourly during market hours. Next update: 2:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell
SELL
1804 shares
2026-03-16
Jill G Mcconnell
SELL
5061 shares
2026-03-10
Robert Parks
SELL
1927 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$203 | 52 HOLD |
